Prelude Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $726K | Buy |
49,057
+13,148
| +37% | +$195K | 0.07% | 343 |
|
|
2025
Q1 | $643K | Buy |
+35,909
| New | +$643K | 0.05% | 370 |
|
|
2024
Q3 | – | Sell |
-107,222
| Closed | -$881K | – | 1449 |
|
|
2024
Q2 | $881K | Buy |
107,222
+24,800
| +30% | +$204K | 0.06% | 303 |
|
|
2024
Q1 | $635K | Buy |
82,422
+54,000
| +190% | +$416K | 0.03% | 469 |
|
|
2023
Q4 | $256K | Buy |
+28,422
| New | +$256K | 0.02% | 712 |
|
|
2021
Q1 | – | Sell |
-79,528
| Closed | -$2.17M | – | 1393 |
|
|
2020
Q4 | $2.17M | Sell |
79,528
-55,552
| -41% | -$1.51M | 0.06% | 110 |
|
|
2020
Q3 | $2.49M | Buy |
+135,080
| New | +$2.49M | 0.12% | 55 |
|
|
2020
Q1 | – | Sell |
-800
| Closed | -$11K | – | 1561 |
|
|
2019
Q4 | $11K | Buy |
+800
| New | +$11K | ﹤0.01% | 1230 |
|
|
2018
Q4 | – | Sell |
-5,287
| Closed | -$152K | – | 1745 |
|
|
2018
Q3 | $152K | Buy |
5,287
+1,787
| +51% | +$51.4K | 0.01% | 593 |
|
|
2018
Q2 | $95K | Buy |
3,500
+500
| +17% | +$13.6K | 0.01% | 735 |
|
|
2018
Q1 | $67K | Buy |
+3,000
| New | +$67K | ﹤0.01% | 868 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1587 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1774 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1762 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1724 |
|
|
2016
Q4 | – | Sell |
-11,245
| Closed | -$252K | – | 1723 |
|
|
2016
Q3 | $252K | Buy |
11,245
+5,766
| +105% | +$129K | 0.03% | 447 |
|
|
2016
Q2 | $98K | Buy |
5,479
+995
| +22% | +$17.8K | 0.01% | 727 |
|
|
2016
Q1 | $61K | Buy |
4,484
+984
| +28% | +$13.4K | 0.01% | 856 |
|
|
2015
Q4 | $68K | Buy |
3,500
+764
| +28% | +$14.8K | 0.01% | 891 |
|
|
2015
Q3 | $55K | Buy |
2,736
+1,736
| +174% | +$34.9K | 0.01% | 959 |
|
|
2015
Q2 | $33K | Buy |
+1,000
| New | +$33K | ﹤0.01% | 1173 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 2080 |
|